BioSpace News Archive

Mirati Therapeutics Inc. reported financial results for the fourth quarter and full-year ended December 31, 2017.

The American Diabetes Association is deeply concerned by the new guidance, “Hemoglobin A1C Targets for Glycemic Control with Pharmacologic Therapy for Nonpregnant Adults with Type 2 Diabetes Mellitus: A Guidance Statement Update From the American College of Physicians,” published in the Annals of Internal Medicine on March 5, 2018.

Pfizer Inc. announced a positive outcome from today’s U.S. Food and Drug Administration (FDA) Gastrointestinal Drugs Advisory Committee (GIDAC) meeting.

Tyber Medical LLC announces the launch of TyFix™, an all-in-one extremity joint fixation system.

Technavio has announced their latest report on stem cell therapy for multiple sclerosis for the period 2018-2022

Quality Pain Care LLC is pleased to announce they now offer GAINSWave™!

Option Care Enterprises, Inc. has been selected by Theratechnologies Inc. as an infusion provider for Trogarzo™ (ibalizumab-uiyk) Injection, an intravenous (IV) infusion for the treatment of multidrug resistant human immunodeficiency virus type 1 (HIV-1) infections.

PrescribeWellness announced that it has partnered with life sciences research consultancy Venebio Group to leverage the company’s new prescription opioid risk assessment tool, Venebio Opioid Advisor™ (VOA).

Zimmer Biomet Holdings Inc. announced that it has priced an offering of $450 million principal amount of its floating rate senior unsecured notes due 2021 and $300 million principal amount of its 3.700% senior unsecured notes due 2023.

Soin Neuroscience has received IRB (institutional review board) approval to commence a clinical case series to study spinal cord stimulator algorithms in patients who suffer from back pain.